Genmab — Maj 2017
-
Der må komme noget helt vildt...nogen må vide noget
-
Er det kl. 17:00 regnskabet offentliggøres?
-
ja
-
Mama mia, det bliver sku spændende
-
1.407 blev flashet forleden.
-
lukkekurs 1403
-
Sønnen ligger med x4 i familiens lille Nordnetdepot. Ham har jeg snart i telefonen.
-
Han skal ikke prale for meget har brændt sig gevaldigt tidligere i år på de dersens certifikater.
-
Det er nogle hidsige papirer.
-
• USD 255 million in net sales of DARZALEX
(daratumumab); resulting in royalty income of DKK 211 million
• DARZALEX received positive opinion from European regulatory authorities for relapsed or refractory multiple myeloma
• Judith Klimovsky, MD appointed Chief Development Officer
• Phase II study of daratumumab in non-Hodgkin's lymphoma (CARINA) did not proceed to stage 2 of trial -
Jeg er tungt lastet i Bullx4....dejligt. Rigtigt Helge, men er man lidt heldig og lidt dygtig kom man også igennem den periode
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind